Skip to main content
SpringerLink
Log in

Cystic Fibrosis: A Successful Model of Transition of Care and Lessons Learned

  • Chapter
  • First Online:
Sleep Medicine

  • 300 Accesses

Abstract

Cystic fibrosis is the most common genetic disease in the Caucasian population and can lead to multisystem dysfunction, significant respiratory morbidity, and limited life span. The treatment burden to maintain health in this condition is significant and doesn’t guarantee longevity. This chapter reviews cystic fibrosis and its impact on the human body as well as the history of care in this patient population. It also highlights the progress that has been made in the care of people with CF, which now obviates other needs such as preparing these patients to be successful adults.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Andersen DH. Cystic fibrosis of the pancreas and its relation to celiac disease. Am J Dis Child. 1938;56:344.

    Article  Google Scholar 

  2. Sanders DB, Fink AK. Background and epidemiology. Pediatr Clin N Am. 2016;63(4):567–84.

    Article  Google Scholar 

  3. Find a CF Care Center. https://www.cff.org/ccd/. Accessed 29 June 2020.

  4. Cystic Fibrosis Foundation. Patient registry 2018 annual report. Bethesda, MD: Cystic FIbrosis Foundation; 2019.

    Google Scholar 

  5. Stoltz DA, Meyerholz DK, Welsh MJ. Origins of cystic fibrosis lung disease. N Engl J Med. 2015;372(4):351–62.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Elborn JS. Cystic fibrosis. Lancet. 2016;388(10059):2519–31.

    Article  CAS  PubMed  Google Scholar 

  7. Davies JC, Ebdon AM, Orchard C. Recent advances in the management of cystic fibrosis. Arch Dis Child. 2014;99(11):1033–6.

    Article  PubMed  Google Scholar 

  8. Gilligan PH. Infections in patients with cystic fibrosis: diagnostic microbiology update. Clin Lab Med. 2014;34(2):197–217.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Pittman JE, Calloway EH, Kiser M, et al. Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease. Pediatr Pulmonol. 2011;46(5):497–504.

    Article  PubMed  Google Scholar 

  10. Bar-on O, Mussaffi H, Mei-zahav M, et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cyst Fibros. 2015;14(1):53–62.

    Article  PubMed  Google Scholar 

  11. Ledder O, Haller W, Couper RT, Lewindon P, Oliver M. Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations. J Gastroenterol Hepatol. 2014;29(12):1954–62.

    Article  PubMed  Google Scholar 

  12. Olivier AK, Gibson-corley KN, Meyerholz DK. Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology. Am J Physiol Gastrointest Liver Physiol. 2015;308(6):G459–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ode KL, Frohnert B, Laguna T, et al. Oral glucose tolerance testing in children with cystic fibrosis. Pediatr Diabetes. 2010;11(7):487–92.

    Article  CAS  PubMed  Google Scholar 

  14. Ode KL, Moran A. New insights into cystic fibrosis-related diabetes in children. Lancet Diabetes Endocrinol. 2013;1(1):52–8.

    Article  CAS  PubMed  Google Scholar 

  15. Colombo C, Battezzati PM, Crosignani A, et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology. 2002;36(6):1374–82.

    Article  PubMed  Google Scholar 

  16. Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros. 2011;10(Suppl 2):S29–36.

    Article  PubMed  Google Scholar 

  17. Van der Doef HP, Kokke FT, Van Derent CK, Houwen RH. Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation. Curr Gastroenterol Rep. 2011;13(3):265–70.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Sathe M, Houwen R. Meconium ileus in cystic fibrosis. J Cyst Fibros. 2017;16(Suppl 2):S32–9.

    Article  PubMed  Google Scholar 

  19. Van der Doef HP, Slieker MG, Staab D, et al. Association of the CLCA1 p.S357N variant with meconium ileus in European patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2010;50(3):347–9.

    Article  PubMed  Google Scholar 

  20. Dray X, Bienvenu T, Desmazes-dufeu N, Dusser D, Marteau P, Hubert D. Distal intestinal obstruction syndrome in adults with cystic fibrosis. Clin Gastroenterol Hepatol. 2004;2(6):498–503.

    Article  PubMed  Google Scholar 

  21. Ahmad A, Ahmed A, Patrizio P. Cystic fibrosis and fertility. Curr Opin Obstet Gynecol. 2013;25(3):167–72.

    Article  PubMed  Google Scholar 

  22. Sueblinvong V, Whittaker LA. Fertility and pregnancy: common concerns of the aging cystic fibrosis population. Clin Chest Med. 2007;28(2):433–43.

    Article  PubMed  Google Scholar 

  23. Boyd JM, Mehta A, Murphy DJ. Fertility and pregnancy outcomes in men and women with cystic fibrosis in the United Kingdom. Hum Reprod. 2004;19(10):2238–43.

    Article  PubMed  Google Scholar 

  24. Osmundo Junior GS, Athanazio RA, Rached SZ, Francisco RPV. Maternal and perinatal outcomes in pregnant women with cystic fibrosis. Rev Bras Ginecol Obstet. 2019;41(4):230–5.

    Article  PubMed  Google Scholar 

  25. GotTransition.org. Got Transition®—Health Care Providers. 2020. https://gottransition.org/providers/index.cfm. Accessed 21 June 2020.

  26. Tuchman L, Schwartz M. Health outcomes associated with transition from pediatric to adult cystic fibrosis care. Pediatrics. 2013;132(5):847–53.

    Article  PubMed  Google Scholar 

  27. Weissberg-benchell J, Shapiro JB. A review of interventions aimed at facilitating successful transition planning and transfer to adult care among youth with chronic illness. Pediatr Ann. 2017;46(5):e182–7.

    Article  PubMed  Google Scholar 

  28. Meadows AK, Bosco V, Tong E, Fernandes S, Saidi A. Transition and transfer from pediatric to adult care of young adults with complex congenital heart disease. Curr Cardiol Rep. 2009;11(4):291–7.

    Article  Google Scholar 

  29. Tuchman LK, Schwartz LA, Sawicki GS, Britto MT. Cystic fibrosis and transition to adult medical care. Pediatrics. 2010;125(3):566–73. https://doi.org/10.1542/peds.2009-2791.

    Article  PubMed  Google Scholar 

  30. https://www.cff.org/Care/Clinical-Care-Guidelines/Age-Specific-Clinical-Care-Guidelines/Adult-Care-Clinical-Care-Guidelines/.

  31. https://www.cff.org/Research/Researcher-Resources/Patient-Registry/Understanding-Changes-in-Life-Expectancy/.

  32. Duguépéroux I, Tamalet A, Sermet-gaudelus I, et al. Clinical changes of patients with cystic fibrosis during transition from pediatric to adult care. J Adolesc Health. 2008;43(5):459–65.

    Article  PubMed  Google Scholar 

  33. Mclaughlin SE, Diener-west M, Indurkhya A, Rubin H, Heckmann R, Boyle MP. Improving transition from pediatric to adult cystic fibrosis care: lessons from a national survey of current practices. Pediatrics. 2008;121(5):e1160–6.

    Article  PubMed  Google Scholar 

  34. https://www.cff.org/Care/Care-Centers/.

  35. Cooley WC, Sagerman PJ. Supporting the health care transition from adolescence to adulthood in the medical home. Pediatrics. 2011;128(1):182–200.

    Article  PubMed  Google Scholar 

  36. Cystic Fibrosis Foundation. Appendix 2. Revised requirements: models for adult CF programs. www.portcf.org/Resources/CFFCareNet/Accreditation%20 Criteria/ADULT%20Program%20Requirements %20and%20Models%2Epdf. Accessed 15 Jan 2010.

  37. Hanghøj S, Boisen KA. Self-reported barriers to medication adherence among chronically ill adolescents: a systematic review. J Adolesc Health. 2014;54(2):121–38.

    Article  PubMed  Google Scholar 

  38. Britto MT, Garrett JM, Dugliss MA, Johnson CA, Majure JM, Leigh MW. Preventive services received by adolescents with cystic fibrosis and sickle cell disease. Arch Pediatr Adolesc Med. 1999;153(1):27–32.

    Article  CAS  PubMed  Google Scholar 

  39. Sawicki GS, Sellers DE, Robinson WM. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros. 2009;8(2):91–6.

    Article  PubMed  Google Scholar 

  40. Callahan ST, Cooper WO. Continuity of health insurance coverage among young adults with disabilities. Pediatrics. 2007;119(6):1175–80.

    Article  PubMed  Google Scholar 

  41. Dziuban EJ, Saab-Abazeed L, Chaudhry SR, et al. Identifying barriers to treatment adherence and related attitudinal patterns in adolescents with cystic fibrosis. Pediatr Pulmonol. 2010;45:450e8.

    Article  Google Scholar 

  42. Kazmerski TM, Sawicki GS, Miller E, et al. Sexual and reproductive health care utilization and preferences reported by young women with cystic fibrosis. J Cyst Fibros. 2018;17(1):64–70.

    Article  PubMed  Google Scholar 

  43. Kazmerski TM, Sawicki GS, Miller E, et al. Sexual and reproductive health behaviors and experiences reported by young women with cystic fibrosis. J Cyst Fibros. 2018;17(1):57–63.

    Article  PubMed  Google Scholar 

  44. Kazmerski TM, Borrero S, Sawicki GS, et al. Provider attitudes and practices toward sexual and reproductive health care for young women with cystic fibrosis. J Pediatr Adolesc Gynecol. 2017;30(5):546–52.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Baylor College of Medicine, Houston, TX, USA

    Taylor Baumann & Tara Lynn Barto

Authors
  1. Taylor Baumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tara Lynn Barto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Taylor Baumann .

Editor information

Editors and Affiliations

  1. Department of Medicine, Baylor College of Medicine, Houston, TX, USA

    Amir Sharafkhaneh

  2. University of Missouri School of Medicine, Department of Child Health and the Child Health Research Institute, Columbia, MO, USA

    David Gozal

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Baumann, T., Barto, T.L. (2023). Cystic Fibrosis: A Successful Model of Transition of Care and Lessons Learned. In: Sharafkhaneh, A., Gozal, D. (eds) Sleep Medicine. Springer, Cham. https://doi.org/10.1007/978-3-031-30010-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-30010-3_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-30009-7

  • Online ISBN: 978-3-031-30010-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation